Search Results for: search.php

Peripheral artery occlusive disease (PAOD) ranks among the most frequent chronic diseases worldwide. Common therapies comprise mechanical interventions, which are not suitable for a considerable number of patients. We offer a new pharmaceutical, achieving an almost healthy blood flow due to an increased growth of collateral vessels. For that immune cells of the patient are used, giving reason to expect a good tolerance and thereby avoiding rejection reactions and the transmission of pathogens.

Graft versus Host Disease (GVHD) is one of the major complications associated with transplantation. It is caused by donor T cells, which recognize the genetically dissimilar recipient and therefore attack the host’s body cells. At present there is no effective therapy available. We offer a simple method, whereby the transplant once is treated ex vivo with a well known substance prior to transplantation. For that only a very low concentration of the substance and a short incubation time are used. Remarkably, GVHD is reduced significantly. Due to the ex vivo treatment no side effects are expected.

Sarah Crowley, of the Environment and Sustainability Institute at the University of Exeter's Penryn Campus, explored the history of the camel in Australia,…

This is the first time such a pair could be found in an ordinary galaxy. They were discovered because they ripped apart a star when ESA’s space observatory…

Many research projects study the effects of temperature and precipitation on the global distribution of plant and animal species. However, an important…

Working with UW astronomer Eric Agol, doctoral student Ethan Kruse has confirmed the first “self-lensing” binary star system — one in which the mass of the…